Compare Eli Lilly And Co (LLY) vs Redwire Corporation (RDW) Price & Performance

Eli Lilly And CoTrade

Redwire CorporationTrade

Price performance (Past 24H)

Key statistics

Eli Lilly And Co vs Redwire Corporation — how do they compare? Eli Lilly And Co trades at $1,174.08 (market cap $1.02T), while Redwire Corporation trades at $9.46 (market cap $2.05B). The key difference: Eli Lilly And Co is far larger — about 497.6× Redwire Corporation's market cap, and Eli Lilly And Co pays a 0.6% dividend while Redwire Corporation pays none. Which is the better fit depends on your goals.

	LLY	RDW
Market Cap	$1.02T	$2.05B
Sector	Health	Technology
52-Week High	$1.24K	$25.90
52-Week Low	$625.65	$5.06
Enterprise Value	$1.06T	$2.12B
Dividend Yield	0.6%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Eli Lilly And Co

No Aura AI signal available yet.

Redwire Corporation

RDW trades at $8.60, down 1.78% on the day, with a bearish technical signal despite bullish oscillators. The company reported a net loss of $226.55 million in 2025, with negative margins and cash flow from operations. Recent news highlights a record $498 million backlog and contract wins, but concerns over dilution and losses persist. The stock is near its support levels with resistance at $9.

The outlook is mixed: strong analyst buy ratings and a $19 consensus price target suggest upside, but fundamental weaknesses and cash burn pose significant risks. Investment opportunity hinges on execution improving profitability, while key risks include continued losses and competitive pressures in the aerospace sector.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LLY

Over 180 companies develop 200+ PD-1/PD-L1 inhibitors, reshaping cancer treatment landscape.Delveinsight · 3 hours agoBullish Novo Nordisk sues Eli Lilly over misleading GLP-1 drug ads claiming superior weight-loss results.Proactive Investors · 9 hours agoBearish Novo Nordisk sues Eli Lilly over misleading ads on obesity and diabetes drug efficacy.CNBC · 12 hours agoBearish View details →

RDW

Redwire shifts to stronger execution with $498M backlog and improved margins, signaling growth potential.Seeking Alpha · 3 days agoBullish View details →

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

About Redwire Corporation

Redwire Corporation is a pure-play space infrastructure company that provides a wide range of advanced solutions for the next generation of space exploration and utilization. The company's capabilities span critical space technology, including on-orbit servicing, satellite components, space robotics, and digital engineering. Redwire's products and services are used by civil, commercial, and national security customers to enable missions from low Earth orbit to deep space.